Back    Zoom +    Zoom -
CN Set to Optimize Volume-Based Procurement Rules, Strengthen Implementation of Results
Recommend
46
Positive
78
Negative
27
Since 2018, China has carried out 11 batches of national-level centralized volume-based drug procurement, covering 490 drugs, said Shi Zihai, deputy head of the National Healthcare Security Administration (NHSA).

Going forward, the NHSA will focus on improving the price formation mechanism for centralized drug procurement in accordance with the recently issued opinions on improving this mechanism.

Related News Guosen Securities Lists Top 10 HK Stocks by Foreign Net Inflows and Outflows in 1Q26 (Table)
Shi stressed that procurement rules will be optimized based on the characteristics of different categories of drugs, and efforts will be made to strengthen the implementation of selected procurement results.

Auto-translated by AI

AASTOCKS Financial News